Effect of Epicutaneous Immunotherapy vs Placebo on Reaction to Peanut Protein Ingestion Among Children With Peanut AllergyDavid M. Fleischer, Wayne G. Shreffler, Matthew Greenhawt et al.|JAMA|2019Cited by 271
Phase 2a randomized, placebo-controlled study of anti–IL-33 in peanut allergyR. Sharon Chinthrajah, Kari C. Nadeau, Shu Cao et al.|JCI Insight|2019Cited by 188
A Phase 2 Randomized Controlled Multisite Study Using Omalizumab-facilitated Rapid Desensitization to Test Continued vs Discontinued Dosing in Multifood Allergic IndividualsSandra Andorf, Kari C. Nadeau, Rachel G. Robison et al.|EClinicalMedicine|2019Cited by 132
Phase 3 Trial of Epicutaneous Immunotherapy in Toddlers with Peanut AllergyMatthew Greenhawt, Paul Turner, Sayantani Sindher et al.|New England Journal of Medicine|2023Cited by 129
Eosinophilic esophagitis and symptoms possibly related to eosinophilic esophagitis in oral immunotherapyDaniel Petroni, Jonathan M. Spergel|Annals of Allergy Asthma & Immunology|2018Cited by 103